Patient Monitoring Devices Global market - Forecast to 2027

Publishing Date : August, 2020
Report Code : HCMD 0100
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Note: The report would be dispatched after confirmation of payment

Patient monitoring devices assist in continuous measurement of a patient’s health parameters such as heart rate, respiratory rate, blood pressure, blood oxygen saturation and many other parameters which have become a common feature of all healthcare settings. The Patient monitoring global market is expected to grow at a mid single digit CAGR fom 2020 to 2027 to reach $42,974.9 million by 2027. The increase in the rate of surgeries and diseased population requires continuous monitoring, increasing demand for portable and remote patient monitoring and increasing funding and investment in patient monitoring are driving the market growth. However, the high cost of patient monitoring devices, stringent regulatory approvals for products, Patient safety and inaccuracy concerns associated with patient monitoring devices, increased product recalls are restraining the market growth.

The patient monitoring devices global market is segmented based on device, portability, end-users and geography. The devices market is segmented into neuromonitoring, hemodynamic monitoring, blood glucose monitoring, cardiac monitoring, fetal & neonatal care monitoring, respiratory care monitoring, multi-parameter monitoring, temperature monitoring and remote patient monitoring. According to IQ4I research, Blood glucose monitoring commanded the largest revenue in 2020 and expected to grow at a low single digit CAGR from 2020 to 2027. Remote patient monitoring is expected to grow at a high single digit CAGR from 2020 to 2027 due to increasing demand by patients for home healthcare and increasing connectivity of rural areas.

The neuromonitoring devices global market is further segmented into electroencephalography (EEG) devices, cerebral oximeters, intracranial pressure (ICP) monitors, magnetoencephalography (MEG) and electromyography machines (EMG). Among them, the EEG devices segment commanded the largest revenue in 2020 is expected to grow at a high single digit CAGR from 2020 to 2027. Increasing the incidence of neurological diseases, expansion of application to new areas such as pain monitoring are the factors driving the market growth.

The hemodynamic monitoring devices global market is classified into Blood pressure monitors and cardiac output monitors. Among them, the Blood pressure monitoring devices commanded the largest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027. An increase in the incidence of cardiovascular diseases due to lifestyle changes and rising demand for patient monitoring devices in non-hospital settings are the factors driving the market.

The blood glucose monitoring devices global market is classified into SBGM and CGM. Among the segments, CGM generated the largest revenue in 2020 and is expected to grow at a high single digit CAGR from 2020 to 2027.

The cardiac monitoring device global market is further segmented into event monitors, 12-Lead ECG and Holter monitors, among these, Holter monitor commanded the largest revenue in 2020 and expected to grow at a mid single digit CAGR from 2020 to 2027. Event Monitors market is expected to grow at a high single digit CAGR from 2020 to 2027.

The fetal and Neonatal device global market is classified into fetal monitors, fetal Doppler, infant incubators and neonatal monitoring devices. Among these, fetal monitors commanded the largest revenue in 2020 and expected to grow at a low single digit CAGR from 2020 to 2027. Infant Incubators market is expected to grow at a mid single digit CAGR from 2020 to 2027.

The respiratory care monitoring devices global market is classified into capnography, spirometer, Polysomnography (PSG), Pulse oximetry and others. Among these, Pulse oximeter commanded the largest revenue in 2020 and is expected to grow at a low single digit CAGR from 2020 to 2027. Rising incidence of respiratory and cardiac disorders, rising adoption in homecare settings, growing demand for wireless pulse oximeters and launch of convenient fingertip and wrist pulse oximeters are the factors driving the market. The Capnography devices segment is expected to grow a high single digit CAGR from 2020 to 2027.

The Multi-parameter monitoring devices global market is segmented into High acuity, Mid-acuity, and Low-acuity devices. Among the multi-parameter monitoring devices, high acuity devices commanded the largest revenue in 2020 and expected to grow at a low single digit CAGR from 2020 to 2027. The integration of advanced technology within the high-acuity multi-parameter patient monitors has fostered its adoption in intensive care units and hospitals that help in the treatment of several chronic diseases are the factors driving the market and low acuity segment is expected to grow at a low single digit CAGR from 2020 to 2027. Low-acuity monitors usually have a high preference in ambulatory surgical centers and hospitals because they are easy to use, accurate, mobile and low price as compared to the high-acuity multi-parameter patient monitors are making the device of choice.

The temperature monitoring devices global market is classified into digital thermometers, Infrared (IR) thermometers, and others (thermometer strips). Among them, the IR thermometer commanded the largest revenue in 2020 and is expected to grow at a strong mid single digit CAGR from 2020 to 2027. These devices do not involve touching or contacting anybody's surface so the risk of cross-infection is negligible, the increasing prevalence of chronic and infectious diseases driving the market as well.

The remote patient monitoring (RPM) devices are classified into hemodynamic monitoring devices, neuromonitoring devices, cardiac monitoring devices and multi-parameter monitoring devices and others. Among these, the Cardiac monitoring segment commanded the largest revenue in 2020 and is expected to grow at a high single digit CAGR from 2020 to 2027. An increase in the prevalence of the cardiac disorder, an increase in the prevalence of the geriatric population who are more prone to chronic disorders are the factors that increase the usage of RPM devices. Other remote patient monitoring devices such as remote respiratory monitoring devices and home dialysis devices are expected to be the fastest-growing segment with a high double digit CAGR from 2020 to 2027.

The patient monitoring devices global market is further segmented based on the portability into stationary, portable, wearable and implantable. Among these, portable commanded the largest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027.

The patient monitoring devices global market based on end-user is segmented into hospital, ambulatory, homecare and others. Among these, the hospital commanded the largest revenue in 2020 and is expected to grow at a low single digit CAGR from 2020 to 2027. The home care market is expected to be the fastest-growing segment with a mid single digit CAGR from 2020 to 2027 due to the improvement and acceptance of home care devices has increased.

The market based on geographies is segmented into North America, Europe, Asia Pacific and the Rest of the world regions. Among these, North America commanded the largest share in 2020 and the market is expected to grow at a low single digit CAGR from 2020 to 2027. An increase in patient population and an increase in funding on developing patient monitoring devices are the factors driving the market. Asia Pacific is expected to grow at a mid single digit CAGR from 2020 to 2027.

Major players in the patient monitoring devices global market are Medtronic, PLC (Ireland), Dexcom, Inc. (U.S.), Masimo Corporation (Switzerland), Abbott Laboratories (U.S.), Nihon Kohden Corporation (Japan), Edwards Lifesciences Corporation (U.S.), GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Hill-Rom Holdings, Inc. (U.S.), Natus Medical, Inc. (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), and Dragerwerk AG & Co. KGaA (Germany).

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     SCOPE OF THE REPORT
    • 2.3     REPORT DESCRIPTION
    • 2.4     MARKETS COVERED
    • 2.5     STAKEHOLDERS
    • 2.6     RESEARCH METHODOLOGY
      • 2.6.1     MARKET SIZE ESTIMATION
      • 2.6.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.6.3     SECONDARY SOURCES
      • 2.6.4     PRIMARY SOURCES
      • 2.6.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.6.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.6.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     INCREASE IN THE RATE OF SURGERIES AND DISEASED POPULATION REQUIRE CONTINUOUS MONITORING.
        • 3.3.1.2     INCREASING DEMAND FOR PORTABLE AND REMOTE PATIENT MONITORING DEVICES.
        • 3.3.1.3     INCREASING FUNDING AND INVESTMENT IN PATIENT MONITORING TECHNOLOGIES.
        • 3.3.1.4     INCREASE IN DEMAND FOR PATIENT MONITORING DEVICES IN EMERGING NATIONS
        • 3.3.1.5     FAVORABLE REIMBURSEMENT POLICIES
        • 3.3.1.6     TECHNOLOGICAL ADVANCEMENTS
        • 3.3.1.7     AVAILABILITY OF SERVICES SUCH AS HOME HEALTHCARE AND NURSING CARE INCREASING THE DEMAND FOR THE USE OF PATIENT MONITORING DEVICES
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     HIGH COST OF PATIENT MONITORING DEVICES
        • 3.3.2.2     PATIENT SAFETY ISSUES AND INACCURACY CONCERN ASSOCIATED WITH PATIENT MONITORING DEVICES
        • 3.3.2.3     INCREASED PRODUCT RECALLS
        • 3.3.2.4     LACK OF CYBER-SECURITY IN WIRELESS PATIENT MONITORING DEVICES
        • 3.3.2.5     STRINGENT REGULATORY REQUIREMENTS FOR NEW PRODUCTS
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
        • 3.4.1.1     ISO 9001: 2015 QUALITY MANAGEMENT SYSTEM
        • 3.4.1.2     ISO 13485 MEDICAL DEVICES
      • 3.4.2     U.S.
      • 3.4.3     CANADA
      • 3.4.4     EUROPE
      • 3.4.5     CHINA
      • 3.4.6     INDIA
      • 3.4.7     JAPAN
    • 3.5     TECHNOLOGICAL ADVANCEMENTS
      • 3.5.1     BIOSTICKER
      • 3.5.2     ARTIFICIAL INTELLIGENCE IN PATIENT MONITORING DEVICES
      • 3.5.3     WEARABLE PATIENT MONITORING DEVICES
      • 3.5.4     IOT IN PATIENT MONITORING SYSTEM
      • 3.5.5     HOME DIALYSIS REMOTE PATIENT MONITORING SYSTEM
      • 3.5.6     SMART ALGORITHMS INTEGRATED HOLTER MONITORING SYSTEMS
      • 3.5.7     FUNCTIONAL NEAR-INFRARED SPECTROSCOPY (FNIRS)
      • 3.5.8     A TRICORDER PHOTOTYPE FOR DIAGNOSIS AND MONITORING OF MULTI PARAMETER AT HOME
      • 3.5.9     WEARABLE TECHNOLOGY FOR CONTINUOUS, NON-INVASIVE BLOOD PRESSURE MONITORING
      • 3.5.10     SMART SPEAKERS FOR MONITORING CARDIAC ARREST
      • 3.5.11     WIRELESS NEONATAL BODY MONITORS
      • 3.5.12     LIQUID METAL BIOSENSORS FOR MONITORING
    • 3.6     PORTER’S FIVE FORCE ANALYSIS
      • 3.6.1     THREAT OF NEW ENTRANTS
      • 3.6.2     THREAT OF SUBSTITUTES
      • 3.6.3     RIVALRY AMONG EXISTING COMPETITORS
      • 3.6.4     BARGAINING POWER OF SUPPLIERS
      • 3.6.5     BARGAINING POWER OF BUYERS
    • 3.7     SUPPLY CHAIN ANALYSIS
    • 3.8     CLINICAL TRIALS
    • 3.9     MARKET SHARE ANALYSIS
      • 3.9.1     PATIENT MONITORING DEVICES GLOBAL MARKET SHARE ANALYSIS
      • 3.9.2     EEG GLOBAL MARKET SHARE ANALYSIS
      • 3.9.3     CEREBRAL OXIMETER GLOBAL MARKET SHARE ANALYSIS
      • 3.9.4     ICP GLOBAL MARKET SHARE ANALYSIS
      • 3.9.5     BP MONITOR GLOBAL MARKET SHARE ANALYSIS
      • 3.9.6     CARDIAC OUTPUT MONITORS GLOBAL MARKET SHARE ANALYSIS
      • 3.9.7     CONTINUOUS GLUCOSE MONITORING GLOBAL MARKET SHARE ANALYSIS
      • 3.9.8     CARDIAC MONITORING DEVICES GLOBAL MARKET SHARE ANALYSIS
      • 3.9.9     PULSE OXIMETER GLOBAL MARKET SHARE ANALYSIS
      • 3.9.10     CAPNOGRAPHY GLOBAL SHARE ANALYSIS
      • 3.9.11     MULTIPARAMETER MONITORS DEVICES GLOBAL MARKET SHARE ANALYSIS
      • 3.9.12     REMOTE PATIENT MONIORING DEVICES GLOBAL MARKET SHARE ANALYSIS
      • 3.9.13     TEMPERATURE MONITOR GLOBAL MARKET SHARE ANALYSIS
      • 3.9.14     MOBILE CARDIAC TELEMETRY GLOBAL MARKET SHARE ANALYSIS
    • 3.1     PATIENT MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE
      • 3.10.1     NEUROMONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE
      • 3.10.2     CARDIAC MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE
      • 3.10.3     FETAL AND NEONATAL MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE
      • 3.10.4     RESPIRATORY MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE
      • 3.10.5     TEMPERATURE MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE
      • 3.10.6     HEMODYNAMIC MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE
      • 3.10.7     MULTI-PARAMETER MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE
      • 3.10.8     BLOOD GLUCOSE MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE
  • 4     PATIENT MONITORING DEVICES MARKET, BY DEVICES
    • 4.1     INTRODUCTION
    • 4.2     NEUROMONITORING DEVICES
      • 4.2.1     ELECTROENCEPHALOGRAPH (EEG)
        • 4.2.1.1     8-CHANNEL EEG
        • 4.2.1.2     21-CHANNEL EEG
        • 4.2.1.3     25-CHANNEL EEG
        • 4.2.1.4     32-CHANNEL EEG
        • 4.2.1.5     40-CHANNEL EEG
        • 4.2.1.6     MULTI-CHANNEL EEG
      • 4.2.2     CEREBRAL OXIMETER
        • 4.2.2.1     CEREBRAL OXIMETER MONITOR
        • 4.2.2.2     CEREBRAL OXIMETER SENSORS
        • 4.2.2.3     SINGLE EMITTER DUAL DETECTOR
        • 4.2.2.4     DUAL EMITTER DUAL DETECTOR
        • 4.2.2.5     FOUR EMITTERS DUAL DETECTOR
        • 4.2.2.6     FIVE EMITTERS DUAL DETECTOR
        • 4.2.2.7     OTHER SENSORS
      • 4.2.3     INTRACRANIAL PRESSURE MONITORS (ICP)
      • 4.2.4     MAGNETOENCEPHALOGRAPH (MEG)
      • 4.2.5     ELECTROMYOGRAPH MACHINES (EMG)
    • 4.3     HEMODYNAMIC MONITORING
      • 4.3.1     BLOOD PRESSURE MONITORS
      • 4.3.2     CARDIAC OUTPUT MONITORING
    • 4.4     BLOOD GLUCOSE MONITORS
      • 4.4.1     SELF BLOOD GLUCOSE MONITORING (SBGM)
        • 4.4.1.1     BLOOD GLUCOSE METER
        • 4.4.1.2     BLOOD GLUCOSE TESTING STRIPS
        • 4.4.1.3     LANCETS
        • 4.4.1.4     OTHERS
      • 4.4.2     CONTINUOUS GLUCOSE MONITORING (CGM)
        • 4.4.2.1     GLUCOSE SENSORS
        • 4.4.2.2     TRANSMITTER AND RECEIVERS
    • 4.5     CARDIAC MONITORING DEVICES
      • 4.5.1     12-LEADS ECG MONITORS
      • 4.5.2     EVENT MONITORS
      • 4.5.3     HOLTER MONITORS
    • 4.6     FETAL AND NEONATAL MONITORING DEVICES
      • 4.6.1     FETAL MONITORS
      • 4.6.2     FETAL DOPPLER
      • 4.6.3     INFANT INCUBATORS
      • 4.6.4     NEONATAL MONITORING DEVICES
    • 4.7     RESPIRATORY MONITORING DEVICES
      • 4.7.1     CAPNOGRAPHY
      • 4.7.2     SPIROMETER
        • 4.7.2.1     VOLUMETRIC SPIROMETERS
        • 4.7.2.2     FLOW MEASURING SPIROMETERS
      • 4.7.3     POLYSOMNOGRAPHY DEVICES
      • 4.7.4     PULSE OXIMETERS
        • 4.7.4.1     FINGERTIP PULSE OXIMETERS
        • 4.7.4.2     HANDHELD PULSE OXIMETERS
        • 4.7.4.3     TABLETOP PULSE OXIMETERS
        • 4.7.4.4     OTHER PULSE OXIMETERS
      • 4.7.5     OTHER RESPIRATORY DEVICES
    • 4.8     MULTI-PARAMETER MONITORING DEVICES
      • 4.8.1     HIGH-ACUITY
      • 4.8.2     MID-ACUITY
      • 4.8.3     LOW-ACUITY
    • 4.9     TEMPERATURE MONITORING DEVICES
      • 4.9.1     DIGITAL THERMOMETERS
      • 4.9.2     INFRARED THERMOMETERS (IR THERMOMETERS)
      • 4.9.3     OTHERS (THERMOMETER STRIPS)
    • 4.1     REMOTE PATIENT MONITORING DEVICES (RPM)
      • 4.10.1     REMOTE NEUROMONITORING DEVICES
      • 4.10.2     REMOTE HEMODYNAMIC MONITORING DEVICES
      • 4.10.3     REMOTE CARDIAC MONITORING DEVICES
      • 4.10.4     IMPLANTABLE LOOP RECORDER/ECG MONITOR
      • 4.10.5     MOBILE CARDIAC TELEMETRY (MCT/MCOT)
      • 4.10.6     REMOTE MULTI-PARAMETER MONITORING DEVICES
      • 4.10.7     OTHER REMOTE MONITORING DEVICES
  • 5     PATIENT MONITORING DEVICES GLOBAL MARKET, BY PORTABILITY
    • 5.1     INTRODUCTION
    • 5.2     STATIONARY PATIENT MONITORING
    • 5.3     PORTABLE PATIENT MONITORING
    • 5.4     WEARABLE PATIENT MONITORING
    • 5.5     IMPLANTABLE PATIENT MONITORING
  • 6     PATIENT MONITORING GLOBAL MARKET, BY END-USERS
    • 6.1     INTRODUCTION
    • 6.2     HOSPITALS
    • 6.3     AMBULATORY SURGICAL CENTERS
    • 6.4     HOME HEALTHCARE
    • 6.5     OTHERS (SLEEP CENTERS, CLINICS/PHYSICIAN OFFICES, HOSPICES)
  • 7     PATIENT MONITORING DEVICES GLOBAL MARKET BY REGION
    • 7.1     INTRODUCTION
    • 7.2     NORTH AMERICA
      • 7.2.1     U.S.
      • 7.2.2     REST OF NORTH AMERICA
    • 7.3     EUROPE
      • 7.3.1     GERMANY
      • 7.3.2     FRANCE
      • 7.3.3     U.K.
      • 7.3.4     REST OF E.U.
    • 7.4     APAC
      • 7.4.1     JAPAN
      • 7.4.2     CHINA
      • 7.4.3     INDIA
      • 7.4.4     REST OF APAC
    • 7.5     ROW
      • 7.5.1     BRAZIL
      • 7.5.2     REST OF LATAM
      • 7.5.3     MIDDLE EAST AND OTHERS
  • 8     COMPETITIVE LANDSCAPE
    • 8.1     INTRODUCTION
    • 8.2     APPROVALS
    • 8.3     AGREEMENTS, PARTNERSHIP AND COLLABORATION
    • 8.4     NEW PRODUCT LAUNCH
    • 8.5     ACQUISITION
    • 8.6     OTHERS
  • 9     MAJOR PLAYER PROFILES
    • 9.1     ABBOTT LABORATORIES
      • 9.1.1     OVERVIEW
      • 9.1.2     FINANCIALS
      • 9.1.3     PRODUCT PORTFOLIO
      • 9.1.4     KEY DEVELOPMENTS
      • 9.1.5     BUSINESS STRATEGY
      • 9.1.6     SWOT ANALYSIS
    • 9.2     DEXCOM, INC.
      • 9.2.1     OVERVIEW
      • 9.2.2     FINANCIALS
      • 9.2.3     PRODUCT PORTFOLIO
      • 9.2.4     KEY DEVELOPMENTS
      • 9.2.5     BUSINESS STRATEGY
      • 9.2.6     SWOT ANALYSIS
    • 9.3     DRAGERWERK AG & CO. KGAA
      • 9.3.1     OVERVIEW
      • 9.3.2     FINANCIALS
      • 9.3.3     PRODUCT PORTFOLIO
      • 9.3.4     KEY DEVELOPMENTS
      • 9.3.5     BUSINESS STRATEGY
      • 9.3.6     SWOT ANALYSIS
    • 9.4     EDWARDS LIFESCIENCES CORPORATION.
      • 9.4.1     OVERVIEW
      • 9.4.2     FINANCIALS
      • 9.4.3     PRODUCT PORTFOLIO
      • 9.4.4     KEY DEVELOPMENTS
      • 9.4.5     BUSINESS STRATEGY
      • 9.4.6     SWOT ANALYSIS
    • 9.5     GENERAL ELECTRIC COMPANY (GE HEALTHCARE)
      • 9.5.1     OVERVIEW
      • 9.5.2     FINANCIALS
      • 9.5.3     PRODUCT PORTFOLIO
      • 9.5.4     KEY DEVELOPMENTS
      • 9.5.5     BUSINESS STRATEGY
      • 9.5.6     SWOT ANALYSIS
    • 9.6     HILL-ROM HOLDINGS, INC.
      • 9.6.1     OVERVIEW
      • 9.6.2     FINANCIALS
      • 9.6.3     PRODUCT PORTFOLIO
      • 9.6.4     KEY DEVELOPMENTS
      • 9.6.5     BUSINESS STRATEGY
      • 9.6.6     SWOT ANALYSIS
    • 9.7     KONINKLIJKE PHILIPS N.V.
      • 9.7.1     OVERVIEW
      • 9.7.2     FINANCIALS
      • 9.7.3     PRODUCT PORTFOLIO
      • 9.7.4     KEY DEVELOPMENTS
      • 9.7.5     BUSINESS STRATEGY
      • 9.7.6     SWOT ANALYSIS
    • 9.8     MASIMO CORPORATION
      • 9.8.1     OVERVIEW
      • 9.8.2     FINANCIALS
      • 9.8.3     PRODUCT PORTFOLIO
      • 9.8.4     KEY DEVELOPMENTS
      • 9.8.5     BUSINESS STRATEGY
      • 9.8.6     SWOT ANALYSIS
    • 9.9     MEDTRONIC, PLC
      • 9.9.1     OVERVIEW
      • 9.9.2     FINANCIALS
      • 9.9.3     PRODUCT PORTFOLIO
      • 9.9.4     KEY DEVELOPMENTS
      • 9.9.5     BUSINESS STRATEGY
      • 9.9.6     SWOT ANALYSIS
    • 9.1     NIHON KOHDEN CORPORATION.
      • 9.10.1     OVERVIEW
      • 9.10.2     FINANCIALS
      • 9.10.3     PRODUCT PORTFOLIO
      • 9.10.4     KEY DEVELOPMENTS
      • 9.10.5     BUSINESS STRATEGY
      • 9.10.6     SWOT ANALYSIS
    • 9.11     OMRON CORPORATION
      • 9.11.1     OVERVIEW
      • 9.11.2     FINANCIALS
      • 9.11.3     PRODUCT PORTFOLIO
      • 9.11.4     KEY DEVELOPMENTS
      • 9.11.5     BUSINESS STRATEGY
      • 9.11.6     SWOT ANALYSIS
    • 9.12     SHENZHEN MINDRAY BIO-MEDICAL ELECTRONIC CO., LTD.
      • 9.12.1     OVERVIEW
      • 9.12.2     FINANCIALS
      • 9.12.3     PRODUCT PORTFOLIO
      • 9.12.4     KEY DEVELOPMENTS
      • 9.12.5     BUSINESS STRATEGY
      • 9.12.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 2     NEUROMONITORING DEVICES AVERAGE SELLING PRICE, NUMBER OF UNITS SOLD AND INSTALLED BASE BY REGION, (2020) (NO.S)
      • TABLE 3     CARDIAC MONITORING DEVICES AVERAGE SELLING PRICE, NUMBER OF UNITS SOLD AND INSTALLED BASE, BY REGION, (2020) (NO.S)
      • TABLE 4     FETAL AND NEONATAL MONITORING DEVICES AVERAGE SELLING PRICE, NUMBER OF UNITS SOLD AND INSTALLED BASE, BY REGION, (2020) (NO.S)
      • TABLE 5     RESPIRATORY MONITORING DEVICES AVERAGE SELLING PRICE, NUMBER OF UNITS SOLD AND INSTALLED BASE BY REGION, (2020) (NO.S)
      • TABLE 6     TEMPERATURE MONITORING DEVICES AVERAGE SELLING PRICE AND NUMBER OF UNITS SOLD, BY REGION, (2020) (NO.S)
      • TABLE 7     HEMODYNAMIC MONITORING DEVICES AVERAGE SELLING PRICE, NUMBER OF UNITS SOLD AND INSTALLED BASE, BY REGION, (2020) (NO.S)
      • TABLE 8     MULTI-PARAMETER MONITORING DEVICES AVERAGE SELLING PRICE, NUMBER OF UNITS SOLD AND INSTALLED BASE, BY REGION, (2020) (NO.S)
      • TABLE 9     BLOOD GLUCOSE MONITORING DEVICES AVERAGE SELLING PRICE AND NUMBER OF UNITS SOLD, BY REGION, (2020) (NO.S)
      • TABLE 10     PATIENT MONITORING GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 11     NEUROMONITORING GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 12     NEUROMONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 13     EEG GLOBAL MARKET REVENUE, BY DEVICES, (2019-2027) ($MN)
      • TABLE 14     8-CHANNEL EEG GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 15     21-CHANNEL EEG GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 16     25-CHANNEL EEG GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 17     32-CHANNEL EEG GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 18     40-CHANNEL EEG GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 19     MULTI-CHANNEL EEG GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 20     CEREBRAL OXIMETER GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 21     CEREBRAL OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 22     CEREBRAL OXIMETER MONITOR GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 23     CEREBRAL OXIMETER SENSORS GLOBAL MARKET REVENUE, BY DETECTORS, (2019-2027) ($MN)
      • TABLE 24     CEREBRAL OXIMETER SENSORS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 25     SINGLE EMITTER DUAL DETECTOR GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 26     DUAL EMITTER DUAL DETECTOR GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 27     FOUR EMITTER DUAL DETECTOR GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 28     FIVE EMITTER DUAL DETECTOR GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 29     OTHER SENSORS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 30     ICP MONITOR GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 31     MEG GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 32     EMG GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 33     HEMODYNAMIC MONITORING GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 34     HEMODYNAMIC MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 35     BLOOD PRESSURE MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 36     CARDIAC OUTPUT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 37     BLOOD GLUCOSE MONITORING GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 38     BLOOD GLUCOSE MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 39     SBGM GLOBAL MARKET REVENUE, BY DEVICES, (2019-2027) ($MN)
      • TABLE 40     SBGM GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 41     BLOOD GLUCOSE METERS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 42     BLOOD GLUCOSE TESTING STRIPS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 43     LANCETS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 44     OTHERS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 45     CGM GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 46     CGM GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 47     GLUCOSE SENSORS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 48     TRANSMITTER AND RECEIVER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 49     CARDIAC MONITORING GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 50     CARDIAC MONITOR GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 51     12-LEAD ECG GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 52     EVENT MONITORS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 53     HOLTER MONITORS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 54     FETAL AND NEONATAL MONITORING GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 55     FETAL AND NEONATAL GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 56     FETAL MONITORS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 57     FETAL DOPPLER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 58     INFANT INCUBATOR GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 59     NEONATAL MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 60     RESPIRATORY MONITORING GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 61     RESPIRATORY MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 62     CAPNOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 63     SPIROMETER GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 64     SPIROMETER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 65     VOLUMETRIC SPIROMETER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 66     FLOW MEASURING SPIROMETER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 67     PSG GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 68     PULSE OXIMETER GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 69     PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 70     FINGERTIP PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 71     HANDHELD PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 72     TABLETOP PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 73     OTHER PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 74     OTHER RESPIRATORY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 75     MULTI-PARAMETER MONITORING GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 76     MULTI-PARAMETER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 77     HIGH ACUITY GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 78     MID ACUITY GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 79     LOW ACUITY GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 80     TEMPERATURE MONITORING GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 81     TEMPERATURE MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 82     DIGITAL THERMOMETER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 83     IR THERMOMETER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 84     OTHER THERMOMETER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 85     REMOTE PATIENT MONITORING GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 86     REMOTE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 87     REMOTE NEUROMONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 88     REMOTE HEMODYNAMIC MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 89     REMOTE CARDIAC MONITORING GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 90     REMOTE CARDIAC MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 91     IMPLANTABLE LOOP RECORDER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 92     MOBILE CARDIAC TELEMETRY GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 93     REMOTE MULTI-PARAMETER MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 94     OTHER REMOTE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 95     PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY PORTABILITY, (2019-2027) ($MN)
      • TABLE 96     STATIONARY PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 97     PORTABLE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 98     WEARABLE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 99     IMPLANTABLE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 100     PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY END-USER, (2019-2027) ($MN)
      • TABLE 101     HOSPITAL GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 102     AMBULATORY SURGICAL CENTERS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 103     HOME HEALTHCARE GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 104     OTHER END-USER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 105     PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 106     N.A. PATIENT MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 107     N.A. NEUROMONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 108     N.A. EEG MARKET REVENUE, BY DEVICES, (2019-2027) ($MN)
      • TABLE 109     N.A. CEREBRAL OXIMETER MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 110     N.A. CEREBRAL OXIMETER SENSORS MARKET REVENUE, BY DETECTOR, (2019-2027) ($MN)
      • TABLE 111     N.A. HEMODYNAMIC MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 112     N.A. BLOOD GLUCOSE MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 113     N.A. SBGM MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 114     N.A. CGM MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 115     N.A. CARDIAC MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 116     N.A. FETAL AND NEONATAL CARE MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 117     N.A. RESPIRATORY MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 118     N.A. SPIROMETER MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 119     N.A. PULSE OXIMETER MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 120     N.A. MULTI-PARAMETER MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 121     N.A. TEMPERATURE MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 122     N.A. REMOTE PATIENT MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 123     N.A REMOTE CARDIAC MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 124     N.A. PATIENT MONITORING DEVICES MARKET REVENUE, BY PORTABILITY, (2019-2027) ($MN)
      • TABLE 125     N.A. PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USER, (2019-2027) ($MN)
      • TABLE 126     N.A. PATIENT MONITORING DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
      • TABLE 127     E.U. PATIENT MONITORING MARKET REVENUE, BY DEVICES, (2019-2027) ($MN)
      • TABLE 128     E.U. NEUROMONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 129     E.U. EEG MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 130     E.U. CEREBRAL OXIMETER MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 131     E.U. CEREBRAL OXIMETER SENSORS MARKET REVENUE, BY DETECTOR, (2019-2027) ($MN)
      • TABLE 132     E.U. HEMODYNAMIC MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 133     E.U. BLOOD GLUCOSE MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 134     E.U. SBGM MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 135     E.U. CGM MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 136     E.U. CARDIAC MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 137     E.U. FETAL AND NEONATAL MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 138     E.U. RESPIRATORY MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 139     E.U. SPIROMETER MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 140     E.U. PULSE OXIMETER MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 141     E.U. MULTI-PARAMETER MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 142     E.U. TEMPERATURE MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 143     E.U. REMOTE PATIENT MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 144     E.U. REMOTE CARDIAC MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 145     E.U. PATIENT MONITORING DEVICES MARKET REVENUE, BY PORTABILITY, (2019-2027) ($MN)
      • TABLE 146     E.U. PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USER, (2019-2027) ($MN)
      • TABLE 147     E.U. PATIENT MONITORING DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
      • TABLE 148     APAC PATIENT MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 149     APAC NEUROMONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 150     APAC EEG MARKET REVENUE, BY DEVICES, (2019-2027) ($MN)
      • TABLE 151     APAC CEREBRAL OXIMETER MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 152     APAC CEREBRAL OXIMETER SENSORS MARKET REVENUE, BY DETECTOR, (2019-2027) ($MN)
      • TABLE 153     APAC HEMODYNAMIC MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 154     APAC BLOOD GLUCOSE MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 155     APAC SBGM MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 156     APAC CGM MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 157     APAC CARDIAC MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 158     APAC FETAL AND NEONATAL CARE MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 159     APAC RESPIRATORY MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 160     APAC SPIROMETER MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 161     APAC PULSE OXIMETER MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 162     APAC MULTI-PARAMETER MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 163     APAC TEMPERATURE MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 164     APAC REMOTE PATIENT MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 165     APAC REMOTE CARDIAC MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 166     APAC PATIENT MONITORING DEVICES MARKET REVENUE, BY PORTABILITY, (2019-2027) ($MN)
      • TABLE 167     APAC PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USER, (2019-2027) ($MN)
      • TABLE 168     APAC PATIENT MONITORING DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
      • TABLE 169     ROW PATIENT MONITORING MARKET REVENUE, BY DEVICES, (2019-2027) ($MN)
      • TABLE 170     ROW NEUROMONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 171     ROW EEG MARKET REVENUE, BY DEVICES, (2019-2027) ($MN)
      • TABLE 172     ROW CEREBRAL OXIMETER MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 173     ROW CEREBRAL OXIMETER SENSORS MARKET REVENUE, BY DETECTOR, (2019-2027) ($MN)
      • TABLE 174     ROW HEMODYNAMIC MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 175     ROW BLOOD GLUCOSE MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 176     ROW SBGM MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 177     ROW CGM MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 178     ROW CARDIAC MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 179     ROW FETAL AND NEONATAL MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 180     ROW RESPIRATORY MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 181     ROW SPIROMETER MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 182     ROW PULSE OXIMETER MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 183     ROW MULTI-PARAMETER MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 184     ROW TEMPERATURE MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 185     ROW REMOTE PATIENT MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 186     ROW REMOTE CARDIAC MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN)
      • TABLE 187     ROW PATIENT MONITORING DEVICES MARKET REVENUE, BY PORTABILITY, (2019-2027) ($MN)
      • TABLE 188     ROW PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USER, (2019-2027) ($MN)
      • TABLE 189     ROW PATIENT MONITORING DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
      • TABLE 190     APPROVALS (2018-2020)
      • TABLE 191     AGREEMENTS, PARTNERSHIP AND COLLABORATION (2018-2020)
      • TABLE 192     NEW PRODUCT LAUNCH (2018-2020)
      • TABLE 193     ACQUISITION (2018-2020)
      • TABLE 194     ACQUISITION (2018-2020)
      • TABLE 195     ABBOTT LABORATORIES, INC.: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 196     ABBOTT LABORATORIES, INC.: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 197     ABBOTT LABORATORIES, INC.: MEDICAL DEVICES REVENUE, BY SUB-SEGMENTS, (2017-2019) ($MN)
      • TABLE 198     ABBOTT LABORATORIES, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 199     DEXCOM, INC.: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN)
      • TABLE 200     DEXCOM, INC.: TOTAL REVENUE, BY SEGMENTS (2017-2019) ($MN)
      • TABLE 201     DEXCOM, INC.: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) ($MN)
      • TABLE 202     DRAGERWERK AG & CO. KGAA: TOTAL REVENUE AND R&D EXPENSES (2017–2019) ($MN)
      • TABLE 203     DRAGERWERK AG & CO. KGAA: TOTAL REVENUE, BY SEGMENTS (2017-2019) ($MN)
      • TABLE 204     DRAGERWERK AG & CO. KGAA: TOTAL REVENUE, BY REGION (2017-2019) ($MN)
      • TABLE 205     EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN)
      • TABLE 206     EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE, BY SEGMENTS (2017-2019) ($MN)
      • TABLE 207     EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2017-2019)($MN)
      • TABLE 208     GE COMPANY: TOTAL REVENUE AND R&D EXPENSES (2017 – 2019) ($MN)
      • TABLE 209     GE COMPANY: TOTAL REVENUE, BY SEGMENTS (2017-2019) ($MN)
      • TABLE 210     GE COMPANY: TOTAL REVENUE, BY HEALTHCARE SEGMENT (2017 –2019) ($MN)
      • TABLE 211     GE COMPANY: TOTAL REVENUE, BY GEOGRAPHY (2017 –2019) ($MN)
      • TABLE 212     HILL-ROM HOLDINGS, INC.: TOTAL REVENUE AND R&D EXPENSES (2018 – 2020) (Q2) ($MN)
      • TABLE 213     HILL-ROM HOLDINGS, INC.: TOTAL REVENUE, BY SEGMENTS (2018-2020) (Q2) ($MN)
      • TABLE 214     HILL-ROM HOLDINGS, INC.: TOTAL REVENUE, BY GEOGRAPHY (2018 –2020) (Q2) ($MN)
      • TABLE 215     KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 216     KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 217     KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 218     MASIMO CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN)
      • TABLE 219     MASIMO CORPORATION: TOTAL REVENUE BY SEGMENTS (2017-2019) ($MN)
      • TABLE 220     MASIMO CORPORATION: TOTAL REVENUE, BY REGIONS (2017-2019) ($MN)
      • TABLE 221     MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 222     MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 223     MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 224     NIHON KOHDEN: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN)
      • TABLE 225     NIHON KOHDEN: TOTAL REVENUE, BY BUSINESS SEGMENTS (2017-2019) (Q3) ($MN)
      • TABLE 226     NIHON KOHDEN: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) ($MN)
      • TABLE 227     OMRON CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2017 – 2019) ($MN)
      • TABLE 228     OMRON CORPORATION: TOTAL REVENUE, BY SEGMENTS (2017-2019) ($MN)
      • TABLE 229     OMRON CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2017 –2019) ($MN)

      LIST OF FIGURES

      • FIGURE 1     PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION (2019-2027) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: PATIENT MONITORING DEVICES GLOBAL MARKET
      • FIGURE 3     PATIENT MONITORING DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     PATIENT MONITORING DEVICES GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     PATIENT MONITORING GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
      • FIGURE 6     PATIENT MONITORING DEVICES GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     PATIENT MONITORING DEVICES GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 9     PATIENT GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 10     PATIENT MONITORING DEVICES GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2020 (%)
      • FIGURE 11     EEG GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2020 (%)
      • FIGURE 12     CEREBRAL OXIMETER GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2020 (%)
      • FIGURE 13     ICP GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2020 (%)
      • FIGURE 14     BP MONITOR GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2020 (%)
      • FIGURE 15     CARDIAC OUTPUT MONITORING GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2020 (%)
      • FIGURE 16     CONTINUOUS GLUCOSE MONITORING (CGM) GLOBAL MARKET SHARE, BY KEY PLAYERS, 2020 (%)
      • FIGURE 17     CARDIAC MONITORING DEVICES GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2020 (%)
      • FIGURE 18     PULSE OXIMETER GLOBAL MARKET SHARE, BY KEY PLAYERS, 2020 (%)
      • FIGURE 19     CAPNOGRAPHY GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2020 (%)
      • FIGURE 20     MULTIPARAMETER MONITORS DEVICES GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2020 (%)
      • FIGURE 21     REMOTE PATIENT MONITORING DEVICES GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2020 (%)
      • FIGURE 22     TEMPERATURE MONITOR GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2020 (%)
      • FIGURE 23     MOBILE CARDIAC TELEMETRY GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2020 (%)
      • FIGURE 24     PATIENT MONITORING GLOBAL MARKET SHARE, BY DEVICE (2020) (%)
      • FIGURE 25     NEUROMONITORING GLOBAL MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 26     EEG GLOBAL MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 27     CEREBRAL OXIMETER GLOBAL MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 28     CEREBRAL OXIMETER SENSORS GLOBAL MARKET SHARE, BY DETECTORS (2020 V/S 2027) (%)
      • FIGURE 29     HEMODYNAMIC MONITORING GLOBAL MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 30     BLOOD GLUCOSE MONITORING GLOBAL MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 31     SBGM GLOBAL MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 32     CGM GLOBAL MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 33     CARDIAC MONITORING GLOBAL MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 34     FETAL AND NEONATAL MONITORING GLOBAL MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 35     RESPIRATORY MONITORING GLOBAL MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 36     SPIROMETER GLOBAL MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 37     PULSE OXIMETER GLOBAL MARKET SHARE, BY DEVICES (2020 V/S 2027) (%)
      • FIGURE 38     MULTI-PARAMETER MONITORING GLOBAL MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 39     TEMPERATURE MONITORING GLOBAL MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 40     REMOTE PATIENT MONITORING GLOBAL MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 41     REMOTE CARDIAC MONITORING GLOBAL MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 42     PATIENT MONITORING DEVICES GLOBAL MARKET SHARE, BY PROBABILITY (2020 V/S 2027) (%)
      • FIGURE 43     PATIENT MONITORING DEVICES GLOBAL MARKET SHARE, BY END-USER (2020 V/S 2027) (%)
      • FIGURE 44     HOSPITAL GLOBAL MARKET SHARE, BY REGION (2020 V/S 2027) (%)
      • FIGURE 45     PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION (2019-2027) ($MN), CAGR (%)
      • FIGURE 46     PATIENT MONITORING DEVICES GLOBAL MARKET SHARE BY REGION AND MARKET REVENUE BY COUNTRY, (2020) (%) ($MN)
      • FIGURE 47     N.A. PATIENT MONITORING MARKET SHARE, BY DEVICE (2020) (%)
      • FIGURE 48     N.A. NEUROMONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 49     N.A. EEG MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 50     N.A. CEREBRAL OXIMETER MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 51     N.A. CEREBRAL OXIMETER SENSORS MARKET SHARE, BY DETECTORS (2020 V/S 2027) (%)
      • FIGURE 52     N.A. HEMODYNAMIC MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 53     N.A. BLOOD GLUCOSE MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 54     N.A. SBGM MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 55     N.A. CGM MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 56     N.A. CARDIAC MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 57     N.A. FETAL AND NEONATAL CARE MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 58     N.A. RESPIRATORY MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 59     N.A. SPIROMETERS MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 60     N.A. PULSE OXIMETER MARKET SHARE, BY DEVICES (2020 V/S 2027) (%)
      • FIGURE 61     N.A. MULTI-PARAMETER MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 62     N.A. TEMPERATURE MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 63     N.A. REMOTE PATIENT MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 64     N.A. REMOTE CARDIAC MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 65     N.A. PATIENT MONITORING DEVICES MARKET SHARE, BY PROBABILITY (2020 V/S 2027) (%)
      • FIGURE 66     N.A. PATIENT MONITORING DEVICES MARKET SHARE, BY END-USER (2020 V/S 2027) (%)
      • FIGURE 67     N.A PATIENT MONITORING DEVICES MARKET SHARE, BY COUNTRY (2020 V/S 2027) (%)
      • FIGURE 68     U.S. PATIENT MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 69     U.S. NEUROMONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 70     U.S. BLOOD GLUCOSE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 71     U.S. CARDIAC MONITORING MARKET REVENUE, BY DEVICE (2020 V/S 2027) ($MN)
      • FIGURE 72     U.S. RESPIRATORY MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 73     U.S. MULTI-PARAMETER MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 74     U.S. REMOTE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 75     U.S. PATIENT MONITORING DEVICES MARKET REVENUE, BY PORTABILITY (2020 V/S 2027) ($MN)
      • FIGURE 76     U.S. PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USER (2020 V/S 2027) ($MN)
      • FIGURE 77     REST OF N.A. PATIENT MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 78     REST OF N.A. NEUROMONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 79     REST OF N.A. BLOOD GLUCOSE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 80     REST OF N.A. CARDIAC MONITORING MARKET REVENUE, BY DEVICE (2020 V/S 2027) ($MN)
      • FIGURE 81     REST OF N.A. RESPIRATORY MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 82     REST OF N.A. MULTI-PARAMETER MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 83     REST OF N.A. REMOTE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 84     REST OF N.A. PATIENT MONITORING DEVICES MARKET REVENUE, BY PORTABILITY (2020 V/S 2027) ($MN)
      • FIGURE 85     REST OF N.A. PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USER (2020 V/S 2027) ($MN)
      • FIGURE 86     E.U. PATIENT MONITORING MARKET SHARE, BY DEVICE (2020) (%)
      • FIGURE 87     E.U. NEUROMONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 88     E.U. EEG MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 89     E.U. CEREBRAL OXIMETER MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 90     E.U. CEREBRAL OXIMETER SENSORS MARKET SHARE, BY DETECTOR (2020 V/S 2027) (%)
      • FIGURE 91     E.U. HEMODYNAMIC MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 92     E.U. BLOOD GLUCOSE MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 93     E.U. SBGM MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 94     E.U. CGM MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 95     E.U. CARDIAC MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 96     E.U. FETAL AND NEONATAL MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 97     E.U. RESPIRATORY MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 98     E.U. SPIROMETERS MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 99     E.U. PULSE OXIMETER MARKET SHARE, BY DEVICES (2020 V/S 2027) (%)
      • FIGURE 100     E.U. MULTI-PARAMETER MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 101     E.U. TEMPERATURE MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 102     E.U. REMOTE PATIENT MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 103     E.U. REMOTE CARDIAC MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 104     E.U. PATIENT MONITORING DEVICES MARKET SHARE, BY PROBABILITY (2020 V/S 2027) (%)
      • FIGURE 105     E.U. PATIENT MONITORING DEVICES MARKET SHARE, BY END-USER (2020 V/S 2027) (%)
      • FIGURE 106     E.U PATIENT MONITORING DEVICES MARKET SHARE, BY COUNTRY (2020 V/S 2027) (%)
      • FIGURE 107     GERMANY PATIENT MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 108     GERMANY NEUROMONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 109     GERMANY BLOOD GLUCOSE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 110     GERMANY CARDIAC MONITORING MARKET REVENUE, BY DEVICE (2020 V/S 2027) ($MN)
      • FIGURE 111     GERMANY RESPIRATORY MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 112     GERMANY MULTI-PARAMETER MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 113     GERMANY REMOTE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 114     GERMANY PATIENT MONITORING DEVICES MARKET REVENUE, BY PORTABILITY (2020 V/S 2027) ($MN)
      • FIGURE 115     GERMANY PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USER (2020 V/S 2027) ($MN)
      • FIGURE 116     FRANCE PATIENT MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 117     FRANCE NEUROMONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 118     FRANCE BLOOD GLUCOSE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 119     FRANCE CARDIAC MONITORING MARKET REVENUE, BY DEVICE (2020 V/S 2027) ($MN)
      • FIGURE 120     FRANCE RESPIRATORY MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 121     FRANCE MULTI-PARAMETER MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 122     FRANCE REMOTE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 123     FRANCE PATIENT MONITORING DEVICES MARKET REVENUE, BY PORTABILITY (2020 V/S 2027) ($MN)
      • FIGURE 124     FRANCE PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USER (2020 V/S 2027) ($MN)
      • FIGURE 125     U.K PATIENT MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 126     U.K. NEUROMONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 127     U.K BLOOD GLUCOSE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 128     U.K. CARDIAC MONITORING MARKET REVENUE, BY DEVICE (2020 V/S 2027) ($MN)
      • FIGURE 129     U.K. RESPIRATORY MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 130     U.K. MULTI-PARAMETER MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 131     U.K. REMOTE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 132     U.K. PATIENT MONITORING DEVICES MARKET REVENUE, BY PORTABILITY (2020 V/S 2027) ($MN)
      • FIGURE 133     U.K. PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USER (2020 V/S 2027) ($MN)
      • FIGURE 134     REST OF E.U. PATIENT MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 135     REST OF E.U. NEUROMONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 136     REST OF E.U. BLOOD GLUCOSE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 137     REST OF E.U. CARDIAC MONITORING MARKET REVENUE, BY DEVICE (2020 V/S 2027) ($MN)
      • FIGURE 138     REST OF E.U. RESPIRATORY MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 139     REST OF E.U. MULTI-PARAMETER MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 140     REST OF E.U. REMOTE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 141     REST OF E.U. PATIENT MONITORING DEVICES MARKET REVENUE, BY PORTABILITY (2020 V/S 2027) ($MN)
      • FIGURE 142     REST OF E.U. PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USER (2020 V/S 2027) ($MN)
      • FIGURE 143     APAC PATIENT MONITORING MARKET SHARE, BY DEVICE (2020) (%)
      • FIGURE 144     APAC NEUROMONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 145     APAC EEG MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 146     APAC CEREBRAL OXIMETER MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 147     APAC CEREBRAL OXIMETER SENSORS MARKET SHARE, BY DETECTOR (2020 V/S 2027) (%)
      • FIGURE 148     APAC HEMODYNAMIC MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 149     APAC BLOOD GLUCOSE MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 150     APAC SBGM MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 151     APAC CGM MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 152     APAC CARDIAC MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 153     APAC FETAL AND NEONATAL CARE MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 154     APAC RESPIRATORY MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 155     APAC SPIROMETERS MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 156     APAC PULSE OXIMETER MARKET SHARE, BY DEVICES (2020 V/S 2027) (%)
      • FIGURE 157     APAC MULTI-PARAMETER MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 158     APAC TEMPERATURE MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 159     APAC REMOTE PATIENT MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 160     APAC REMOTE CARDIAC MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 161     APAC PATIENT MONITORING DEVICES MARKET SHARE, BY PROBABILITY (2020 V/S 2027) (%)
      • FIGURE 162     APAC PATIENT MONITORING DEVICES MARKET SHARE, BY END-USER (2020 V/S 2027) (%)
      • FIGURE 163     APAC PATIENT MONITORING DEVICES MARKET SHARE, BY COUNTRY (2020 V/S 2027) (%)
      • FIGURE 164     JAPAN PATIENT MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 165     JAPAN NEUROMONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 166     JAPAN BLOOD GLUCOSE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 167     JAPAN CARDIAC MONITORING MARKET REVENUE, BY DEVICE (2020 V/S 2027) ($MN)
      • FIGURE 168     JAPAN RESPIRATORY MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 169     JAPAN MULTI-PARAMETER MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 170     JAPAN REMOTE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 171     JAPAN PATIENT MONITORING DEVICES MARKET REVENUE, BY PORTABILITY (2020 V/S 2027) ($MN)
      • FIGURE 172     JAPAN PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USER (2020 V/S 2027) ($MN)
      • FIGURE 173     CHINA PATIENT MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 174     CHINA NEUROMONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 175     CHINA BLOOD GLUCOSE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 176     CHINA CARDIAC MONITORING MARKET REVENUE, BY DEVICE (2020 V/S 2027) ($MN)
      • FIGURE 177     CHINA RESPIRATORY MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 178     CHINA MULTI-PARAMETER MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 179     CHINA REMOTE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 180     CHINA PATIENT MONITORING DEVICES MARKET REVENUE, BY PORTABILITY (2020 V/S 2027) ($MN)
      • FIGURE 181     CHINA PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USER (2020 V/S 2027) ($MN)
      • FIGURE 182     INDIA PATIENT MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 183     INDIA NEUROMONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 184     INDIA BLOOD GLUCOSE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 185     INDIA CARDIAC MONITORING MARKET REVENUE, BY DEVICE (2020 V/S 2027) ($MN)
      • FIGURE 186     INDIA RESPIRATORY MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 187     INDIA MULTI-PARAMETER MONITORING MARKET REVENUE, BY DEVICES (2020 V/S ) ($MN)
      • FIGURE 188     INDIA REMOTE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 189     INDIA PATIENT MONITORING DEVICES MARKET REVENUE, BY PORTABILITY (2020 V/S 2027) ($MN)
      • FIGURE 190     INDIA PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USER (2020 V/S 2027) ($MN)
      • FIGURE 191     REST OF APAC PATIENT MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 192     REST OF APAC NEUROMONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 193     REST OF APAC BLOOD GLUCOSE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 194     REST OF APAC CARDIAC MONITORING MARKET REVENUE, BY DEVICE (2020 V/S 2027) ($MN)
      • FIGURE 195     REST OF APAC RESPIRATORY MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 196     REST OF APAC MULTI-PARAMETER MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 197     REST OF APAC REMOTE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 198     REST OF APAC PATIENT MONITORING DEVICES MARKET REVENUE, BY PORTABILITY (2020 V/S 2027) ($MN)
      • FIGURE 199     REST OF APAC PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USER (2020 V/S 2027) ($MN)
      • FIGURE 200     ROW PATIENT MONITORING MARKET SHARE, BY DEVICE (2020) (%)
      • FIGURE 201     ROW NEUROMONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 202     ROW EEG MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 203     ROW CEREBRAL OXIMETER MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 204     ROW CEREBRAL OXIMETER SENSORS MARKET SHARE, BY DETECTOR (2020 V/S 2027) (%)
      • FIGURE 205     ROW HEMODYNAMIC MONITORING DEVICES MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 206     ROW BLOOD GLUCOSE MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 207     ROW SBGM MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 208     ROW CGM MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 209     ROW CARDIAC MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 210     ROW FETAL AND NEONATAL MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 211     ROW RESPIRATORY MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 212     ROW SPIROMETERS MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 213     ROW PULSE OXIMETER MARKET SHARE, BY DEVICES (2020 V/S 2027) (%)
      • FIGURE 214     ROW MULTI-PARAMETER MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 215     ROW TEMPERATURE MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 216     ROW REMOTE PATIENT MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 217     ROW REMOTE CARDIAC MONITORING MARKET SHARE, BY DEVICE (2020 V/S 2027) (%)
      • FIGURE 218     ROW PATIENT MONITORING DEVICES MARKET SHARE, BY PROBABILITY (2020 V/S 2027) (%)
      • FIGURE 219     ROW PATIENT MONITORING DEVICES MARKET SHARE, BY END-USER (2020 V/S 2027) (%)
      • FIGURE 220     ROW PATIENT MONITORING DEVICES MARKET SHARE, BY COUNTRY (2020 V/S 2027) (%)
      • FIGURE 221     BRAZIL PATIENT MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 222     BRAZIL NEUROMONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 223     BRAZIL BLOOD GLUCOSE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 224     BRAZIL CARDIAC MONITORING MARKET REVENUE, BY DEVICE (2020 V/S 2027) ($MN)
      • FIGURE 225     BRAZIL RESPIRATORY MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 226     BRAZIL MULTI-PARAMETER MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 227     BRAZIL REMOTE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 228     BRAZIL PATIENT MONITORING DEVICES MARKET REVENUE, BY PORTABILITY (2020 V/S 2027) ($MN)
      • FIGURE 229     BRAZIL PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USER (2020 V/S 2027) ($MN)
      • FIGURE 230     REST OF LATAM PATIENT MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 231     REST OF LATAM NEUROMONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 232     REST OF LATAM BLOOD GLUCOSE MONITORING DEVICES MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 233     REST OF LATAM CARDIAC MONITORING MARKET REVENUE, BY DEVICE (2020 V/S 2027) ($MN)
      • FIGURE 234     REST OF LATAM RESPIRATORY MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 235     REST OF LATAM MULTI-PARAMETER MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 236     REST OF LATAM REMOTE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 237     REST OF LATAM PATIENT MONITORING DEVICES MARKET REVENUE, BY PORTABILITY (2020 V/S 2027) ($MN)
      • FIGURE 238     REST OF LATAM PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USER (2020 V/S 2027) ($MN)
      • FIGURE 239     MIDDLE EAST AND OTHERS PATIENT MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 240     MIDDLE EAST AND OTHERS NEUROMONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 241     MIDDLE EAST AND OTHERS BLOOD GLUCOSE MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 242     MIDDLE EAST AND OTHERS CARDIAC MONITORING MARKET REVENUE, BY DEVICE (2020 V/S 2027) ($MN)
      • FIGURE 243     MIDDLE EAST AND OTHERS RESPIRATORY MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 244     MIDDLE EAST AND OTHERS MULTI-PARAMETER MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 245     MIDDLE EAST AND OTHERS REMOTE PATIENT MONITORING MARKET REVENUE, BY DEVICES (2020 V/S 2027) ($MN)
      • FIGURE 246     MIDDLE EAST AND OTHERS PATIENT MONITORING DEVICES MARKET REVENUE, BY PORTABILITY (2020 V/S 2027) ($MN)
      • FIGURE 247     MIDDLE EAST AND OTHERS PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USER (2020 V/S 2027) ($MN)
      • FIGURE 248     KEY GROWTH STRATEGIES (2018-2020)
      • FIGURE 249     SWOT: ABBOTT LABORATORIES
      • FIGURE 250     SWOT: DEXCOM, INC.
      • FIGURE 251     SWOT: DRAGERWERK AG & CO. KGAA.
      • FIGURE 252     SWOT: EDWARDS LIFESCIENCES, INC.
      • FIGURE 253     SWOT: GE HEALTHCARE
      • FIGURE 254     SWOT: HILL-ROM HOLDINGS, INC.
      • FIGURE 255     SWOT: KONINKLIJKE PHILIPS N.V.
      • FIGURE 256     SWOT: MASIMO CORPORATION
      • FIGURE 257     SWOT: MEDTRONIC, PLC
      • FIGURE 258     SWOT: NIHON KOHDEN
      • FIGURE 259     SWOT: OMRON HEALTHCARE
      • FIGURE 260     SWOT: SHENZHEN MINDRAY BIO-MEDICAL ELECTRONIC CO., LTD.

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     3M MEDICAL
      • 2     A&D COMPANY LTD.
      • 3     A. MENARINI DIAGNOSTICS S.R.L
      • 4     ABBOTT LABORATORIES
      • 5     ACON LABORATORIES, INC.
      • 6     ADVANCED BRAIN MONITORING, INC.
      • 7     ADVANCED INSTRUMENTATIONS
      • 8     AMERICAN DIAGNOSTIC CORPORATION
      • 9     ANGEL MEDICAL SYSTEMS, INC.
      • 10     ANT NEURO
      • 11     APEX BIOTECHNOLOGY CORPORATION
      • 12     APPLIED CARDIAC SYSTEMS (ACS DIAGNOSTICS)
      • 13     ARKRAY INC.
      • 14     ASCENSIA DIABETES CARE
      • 15     B.BRAUN MELSUNGEN AG
      • 16     BARDY DIAGNOSTICS, INC.
      • 17     BAXTER INTERNATIONAL
      • 18     BEIJING CHOICE ELECTRONIC TECHNOLOGY CO.,LTD
      • 19     BENSON MEDICAL INSTRUMENT
      • 20     BEURER GMBH
      • 21     BIOBEAT
      • 22     BIONET AMERICA, INC.
      • 23     BIONIME CORPORATION
      • 24     BIOTELEMETRY, INC.
      • 25     BIOTEST MEDICAL CORPORATION
      • 26     BIOTRONIK, INC.
      • 27     BITBRAIN
      • 28     BITTIUM CORPORATION
      • 29     BL GROUP PLC(PRESTIGE MEDICAL)
      • 30     BRAIN SCIENTIFIC, INC. (MEMORY MD)
      • 31     BRAINSCOPE COMPANY, INC.
      • 32     BRAVEHEART LIFE
      • 33     BREMED LIMITED
      • 34     CADI SCIENTIFIC PTE LTD
      • 35     CADWELL INDUSTRIES, INC.
      • 36     CARDINAL HEALTH
      • 37     CAREMATIX, INC.
      • 38     CARETAKER MEDICAL
      • 39     CERIBELL, INC.
      • 40     CIRCA SCIENTIFIC, LLC
      • 41     CLARITY MEDICAL PVT. LTD. EMOTIVE, INC.
      • 42     CLEVEMED (CLEVELAND MEDICAL DEVICES, INC.)
      • 43     CMI HEALTH, INC.
      • 44     CNSYSTEMS MEDIZINTECHNIK GMBH
      • 45     COMPUMEDICS
      • 46     CONTEC MEDICAL SYSTEM CO., LTD
      • 47     COOPER COMPANIES, INC. (COOPER SURGICAL, INC.)
      • 48     CORTICARE, INC.
      • 49     DARIO HEALTH CORPORATION
      • 50     DELSYS, INC.
      • 51     DEPISTEO, LLC
      • 52     DEVON INTERNATIONAL GROUP, INC.
      • 53     DEXCOM, INC.
      • 54     DONGGUAN HCS ELECTRONICS
      • 55     DRAGERWERK AG & CO. KGAA
      • 56     EB NEURO S.P.A.
      • 57     ECOM MEDICAL
      • 58     EDWARDS LIFESCIENCE CORPORATION
      • 59     EMCO MEDITEK PVT LTD
      • 60     EMOTIVE, INC.
      • 61     ENTRA HEALTH SYSTEMS
      • 62     EPS BIOTECHNOLOGY CORPORATION
      • 63     EPSIMED, LLC
      • 64     EXERGEN CORPORATION
      • 65     F. HOFFMANN-LA ROCHE AG
      • 66     FIA BIOMED GMBH
      • 67     FIAB SPA
      • 68     FISHER & PAYKEL HEALTHCARE LIMITED
      • 69     FORACARE SUISSE AG
      • 70     FUKUDA DENSHI CO., LTD
      • 71     GE HEALTHCARE
      • 72     GENESIS HEALTH TECHNOLOGY
      • 73     GETINGE AB
      • 74     GLOBALCARE MEDICAL TECHNOLOGY CO., LTD.
      • 75     GRAHAM-FIELD
      • 76     HALMA PLC.
      • 77     HAMAMATSU
      • 78     HEYER MEDICAL AG
      • 79     HILL-ROM HOLDINGS, INC.
      • 80     HMD BIOMEDICAL, INC.
      • 81     HONEYWELL LIFESCIENCES
      • 82     HUNTLEIGH HEALTHCARE
      • 83     ICU MEDICAL
      • 84     IHEALTH LABS, INC.
      • 85     IME-DC GMBH
      • 86     IMOTIONS
      • 87     INFINIUM MEDICALS
      • 88     INFOBIONIC, INC.
      • 89     INFUNIX TECHNOLOGY CO., LTD
      • 90     INTEGRA LIFESCIENCES CORPORATION
      • 91     INTERNATIONAL BIOMEDICAL LTD
      • 92     IRADIMED, INC.
      • 93     I-SENS, INC.
      • 94     IVY MEDICAL
      • 95     KONINKLIJIKE PHILIPS N.V.
      • 96     LCR HALLCREST
      • 97     LIDCO GROUP
      • 98     LIFE PLUS MEDICAL
      • 99     LIFESCAN, INC.
      • 100     LIVONGO, INC.
      • 101     L-TAC MEDICARE
      • 102     LUTECH INDUSTRIES, INC.
      • 103     MARKETLAB, INC.
      • 104     MASIMO CORPORATION
      • 105     MBRAIN TRAIN, LLC
      • 106     MED-BOTICS, LLC
      • 107     MEDGYN PRODUCTS, INC.
      • 108     MEDIAID, INC.
      • 109     MEDIANA CO., LTD
      • 110     MEDICOMP, INC.
      • 111     MEDISM LTD
      • 112     MEDLAB MEDIZINISCHE DIAGNOSEGERÄTE
      • 113     MEDLINE
      • 114     MEDTRONIC, PLC
      • 115     MESPERE LIFESCIENCES
      • 116     MGC DIAGNOSTICS
      • 117     MHC MEDICAL PRODUCTS, LLC
      • 118     MICROLIFE AG
      • 119     MINDCHILD MEDICAL, INC.
      • 120     MONAGHAN MEDICAL CORPORATION
      • 121     MORGAN SCIENTIFIC, INC.
      • 122     NATUS MEDICAL CORPORATION
      • 123     NDD MEDIZINTECHNIK AG(NDD MEDICAL TECHNOLOGIES, INC.)
      • 124     NEOVENTA OBMEDICAL COMPANY
      • 125     NEUROELECTRICS
      • 126     NEUROSOFT S.A
      • 127     NEUROVIGIL, INC.
      • 128     NEUROWAVE
      • 129     NEWMAN MEDICAL
      • 130     NIHON KOHDEN CORPORATION
      • 131     NONIN MEDICAL, INC.
      • 132     NORTH-VISION TECH, INC.
      • 133     NOVA BIOMEDICAL CORPORATION
      • 134     OK BIOTECH CO., LTD
      • 135     OMRON HEALTHCARE CO., LTD
      • 136     ONE DROP
      • 137     OSANG HEALTHCARE CO., LTD
      • 138     OSI SYSTEMS (SPACELABS HEALTHCARE)
      • 139     OWLET BABY CARE
      • 140     PARKS MEDICAL ELECTRONICS SALES, INC.
      • 141     PEPEX BIOMEDICAL
      • 142     PHARMATECH SOLUTIONS, INC.
      • 143     PHILOSYS CO., LTD
      • 144     PODIMETRICS, INC.
      • 145     PRECISION MEDICAL, INC.
      • 146     PREVENTICE
      • 147     PRODIGY DIABETES CARE, LLC
      • 148     PULMONARY CORPORATION
      • 149     RADIANT INNOVATION
      • 150     RAUMEDIC AG
      • 151     RESMED, INC.
      • 152     RETIA MEDICAL
      • 153     SCHILLER AG
      • 154     SCOTTCARE CARDIOVASCULAR SOLUTIONS
      • 155     SENSEONICS HOLDINGS, INC.
      • 156     SHANGHAI 3F ELECTRONICS CO LTD
      • 157     SHENZHEN BRAV ELECTRONIC TECHNOLOGIES
      • 158     SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD
      • 159     SHENZHEN JUMPER MEDICAL EQUIPMENT
      • 160     SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
      • 161     SHENZHEN ZHENGKANG TECHNOLOGY CO., LTD.
      • 162     SHIMMER
      • 163     SINOCARE
      • 164     SKANRAY TECHNOLOGIES PVT LTD
      • 165     SMART METER, LLC
      • 166     SMITHS GROUP PLC
      • 167     SOLARIS TECHNOLOGIES, INC.
      • 168     SOTERA WIRELESS, INC.
      • 169     SOTERIX MEDICAL, INC.
      • 170     SPECTROS CORPORATION
      • 171     SPIEGELBERG GMBH & CO. KG
      • 172     TAIDOC TECHNOLOGY CORPORATION
      • 173     TECHNOCARE MEDISYSTEMS
      • 174     TELCARE
      • 175     TELEFLEX INCORPORATED
      • 176     TERUMO CORPORATION
      • 177     THERMOMEDICS
      • 178     TIANJIN EMPECS MEDICAL DEVICE CO., LTD
      • 179     TRISTAN TECHNOLOGIES, INC.
      • 180     TROYKA MED A.S.
      • 181     VITALOGRAPH
      • 182     VIVACHEK LABORATORIES, INC.
      • 183     VIVALINK, INC.
      • 184     VIVAQUANT
      • 185     VOTEM
      • 186     VYAIRE MEDICAL, INC.
      • 187     WALLACH SURGICAL DEVICES, INC.
      • 188     XUZHOU YONGKANG ELECTRONICS SCIENCE
      • 189     YPSOMED HOLDING AG
      • 190     ZETO, INC.
      • 191     ZYNEX MEDICAL, INC.
      • 192     YPSOMED HOLDING AG (SWITZERLAND)
      • 193     ZETO, INC. (U.S.)
      • 194     ZYNEX MEDICAL, INC. (U.S.)